Postpartum depression pill shows promising results, study finds
Zuranolone is not yet approved by the Food and Drug Administration, but the agency is expected to make a decision in early August.
United States Amy Schacterle Drug Administration American Journal Sage Therapeutics Postpartum Depression
Source: yahoo.com